IM Cannabis Corp. Files March 2024 6-K Report
Ticker: IMCC · Form: 6-K · Filed: Mar 6, 2024 · CIK: 1792030
| Field | Detail |
|---|---|
| Company | Im Cannabis CORP. (IMCC) |
| Form Type | 6-K |
| Filed Date | Mar 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, cannabis
TL;DR
IM Cannabis Corp. filed its March 6-K, confirming its status as a foreign private issuer based in Israel.
AI Summary
IM Cannabis Corp. filed a Form 6-K on March 6, 2024, reporting for the month of March 2024. The company, incorporated in Israel with its principal executive offices at Kibbutz Glil Yam, Central District, Israel, is a foreign private issuer. IM Cannabis Corp. is listed under the SIC code 2833 for Medicinal Chemicals & Botanical Products and has its main business address in Toronto, Canada.
Why It Matters
This filing provides an update on IM Cannabis Corp.'s reporting status as a foreign private issuer, which can affect regulatory requirements and investor information.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) that provides basic company information and does not contain significant new financial or operational disclosures.
Key Numbers
- 001-40065 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- IM Cannabis Corp. (company) — Registrant
- Kibbutz Glil Yam, Central District, Israel (location) — Principal executive offices
- Toronto, Canada (location) — Business address
- 2833 (sic_code) — Standard Industrial Classification
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country, or that it has filed or will file with a stock exchange.
What is IM Cannabis Corp.'s primary industry classification?
IM Cannabis Corp. is classified under SIC code 2833, which pertains to Medicinal Chemicals & Botanical Products.
Where are IM Cannabis Corp.'s principal executive offices located?
The company's principal executive offices are located at Kibbutz Glil Yam, Central District, Israel.
What is the filing date of this Form 6-K?
This Form 6-K was filed on March 6, 2024.
Does IM Cannabis Corp. file annual reports on Form 20-F or 40-F?
The filing indicates that IM Cannabis Corp. files annual reports under cover of Form 20-F.
Filing Stats: 346 words · 1 min read · ~1 pages · Grade level 16 · Accepted 2024-03-06 08:07:44
Filing Documents
- zk2431089.htm (6-K) — 11KB
- exhibit_99-1.htm (EX-99.1) — 59KB
- 0001178913-24-000830.txt ( ) — 71KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 . Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders. Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IM CANNABIS CORP. (Registrant) Date: March 6, 2024 By: /s/ Oren Shuster Name: Oren Shuster Title: Chief Executive Officer and Director EXHIBIT INDEX 99.1 Form 7 - Monthly Progress Report dated March 6, 2024